• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. EUFLEXXA; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. EUFLEXXA; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Patient Problem Pain (1994)
Event Date 11/01/2023
Event Type  Injury  
Event Description
In (b)(6) 2023 i took 3 injections of euflexxa by a doctor into my knees.As i went thru the series of injections i found that other areas of my body would have soreness, my hips, legs, shoulders and especially my lower back.I talked to my doctor and he had no explanation for the soreness but to offer to perform surgery on my knees.Twelve weeks have past since the last injection and i am still trying to deal with the pain not only in my knees but in most of other areas of my body.Some days the pain is so high that i barely get thru my daily activities.I take ibuprofen for the pain but it only last for a few hours.My main purpose for reporting this problem is to find out if others have had similar reactions and to get ideas of other medication that may help with the pain.The pain in my knees is still very noticeable.My name is (b)(6).Thank you for any information you can share with me.Reference reports: mw5152903, mw5152904.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUFLEXXA
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
BIO-TECHNOLOGY GENERAL (ISRAEL) LTD.
MDR Report Key18920624
MDR Text Key337996252
Report NumberMW5152902
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 03/13/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/15/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Was Device Available for Evaluation? No
Patient Sequence Number1
Treatment
ALLERGY MED.; IBUPROFEN.; LISINOPRIL 20 MG 1 A DAY.
Patient Outcome(s) Disability;
Patient Age76 YR
Patient SexFemale
Patient Weight90 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-